Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Robert Mabry"'
Autor:
Thomas Lee, Thomas Barnes, Robert Mabry, Ashley Wong, Chris Wright, David Soto, Kevin Kauffman, Amy Becker, Alex Wesselhoeft, Allen Horhata, Akinola Emmanuel, Akshi Thakkar, Ramya Elangovan, Magnolia Chinn, Sharmistha Kundu, Kristen Ott, Trent Stevens, Yessica Wiryawan, Ian Langer, Rahul Vungutur, Corey Ciullo, Nelson Chau, Renee Wright-Michaud, Meghan Richardson, Jui Dutta-Simmons, Rena Schindler, Junghoon Yang, Paisley Haskell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2a5fc66995454ea9991f85952f8b8513
Autor:
Robert Mabry, Amy Becker, Alex Wesselhoeft, Allen Horhata, Akinola Emmanuel, Thomas Lee, David Soto, Akshi Thakkar, Ramya Elangovan, Magnolia Chinn, Sharmistha Kundu, Kevin Kauffman, Kristen Ott, Trent Stevens, Yessica Wiryawan, Ashley Wong, Ian Langer, Rahul Vungutur, Corey Ciullo, Zifiso Nyoni, Nelson Chau, Thomas Barnes
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Robert Mabry, Andrew Z Feng, Elizabeth K Culyba, Matthew Wallace, Charan K Ramineni, Jianwen Feng, Kevin P Guay, Chang-Ai Xu, Kinjal Mehta, Stephen Farrand, Jin Xu
Publikováno v:
MAbs
IgG(4), a common type of therapeutic antibody, is less stable during manufacturing processes compared with IgG(1). Aggregation and fragmentation are the two main challenges. Here, we report instability of the heavy chain (HC) C-terminal region under
Autor:
Michael Briskin, V Cortez-Retamozo, Igor Feldman, Mohammad Zafari, R Larson, Kumiko Nagashima, Robert Mabry, Jeffrey W. Smith, T Novorantseva, Shaffer, S Sathyanaryananan
Publikováno v:
Cancer Research. 76:P2-11
B7-H4 (VTCN1, B7x, B7S1) is a transmembrane protein belonging to the B7 family of costimulatory proteins and has been shown to inhibit T cell proliferation, cytokine secretion, and cytotoxic lymphocyte (CTL) induction. B7-H4 expressed on tumor cells
Autor:
George Robert Mabry, Christopher Harvey, Matthew Wallace, Ellen Duong, Lauren Pepper, Michael Briskin, Jennifer S. Michaelson, Calvin Johnson, Kutlu G. Elpek, Amanda Hanson, Martin Fan, Tyler R. Simpson, Deborah Law, Monica Gostissa, Sarah Zuerndorfer, Lindsey Shallberg, Stephen Sazinsky, Chengyi J. Shu, Sriram Sathyanarayanan
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239595 (2020)
PLoS ONE
PLoS ONE
Immunotherapy checkpoint inhibitors, such as antibodies targeting PD-1 and CTLA-4, have demonstrated the potential of harnessing the immune system to treat cancer. However, despite encouraging results particularly with respect to survival, only a min
Autor:
Bianka Prinz, K. Dane Wittrup, Gerhild Zauner, Stefan Malafa, Karin Gross, Zehra Visram, Michael B. Battles, Eszter Nagy, Jakub Zmajkovic, Adriana Badarau, Srijib Banerjee, Sabine Maier, Irina Mirkina, Robert Mabry, Harald Rouha, Manuel Zerbs, Tillman U. Gerngross, Ivana Dolezilkova, Barbara Maierhofer, Astrid Teubenbacher, Eric Krauland, Zoltán Magyarics, Gábor Nagy, Michaela Jägerhofer, Lukas Stulik
Publikováno v:
mAbs
Staphylococcus aureus is a major human pathogen associated with high mortality. The emergence of antibiotic resistance and the inability of antibiotics to counteract bacterial cytotoxins involved in the pathogenesis of S. aureus call for novel therap
Autor:
Devin Sok, Paul W. H. I. Parren, Gary L. Gilliland, Lubna Abuqayyas, Wayne A. Marasco, Fridtjof Lund-Johansen, Robert Mabry, Kai Y Xu, Jamie K. Scott, Janice M. Reichert, James S. Huston, James E. Voss, Stefan Barghorn, Gustavo Helguera, Raiees Andrabi, Eshel Ben-Jacob, Juan Carlos Almagro, Stephen Albert Johnston, Juha Laurén, James E. Crowe, Eric Krauland, Matthias Pauthner, Felix Breden, Mathieu Bléry
Publikováno v:
mAbs. 6:577-618
The 24th Antibody Engineering & Therapeutics meeting brought together a broad range of participants who were updated on the latest advances in antibody research and development. Organized by IBC Life Sciences, the gathering is the annual meeting of T
Autor:
Alexey Lugovskoy, Jagath Reddy Junutula, Hans-Peter Gerber, Roland E. Kontermann, Paul Carter, Thierry Wurch, Alain Beck, Robert Mabry
Publikováno v:
mAbs. 5:339-357
The 8th European Antibody Congress (EAC), organized by Terrapin Ltd., was again held in Geneva, Switzerland, following on the tradition established with the 4th EAC. The new agenda format for 2012 included three parallel tracks on: (1) naked antibodi
Autor:
Nels B. Hamacher, Megan M. Lantry, Pallavur V. Sivakumar, Robert Rosler, Brenda L. Stevens, Secil Franke, Craig D. Ostrander, Debra G. Gilbertson, Penny Thompson, Mark Snavely, Cindy Yen, Tom Bukowski, Anitra Wolf, Hank Franklin, Robert Mabry, Dan Ardourel, Kenneth Brasel, Scott R. Presnell, Qi Pan, Julien Susan H, Michael G. Dodds, Amanda Frank, Scott Peterson, Tuyen Vu, Monica Anderson-Haley, Brent Meengs, Sara Underwood, Jennifer A. Brody
Publikováno v:
mAbs. 2:20-34
Targeting angiogenesis is a promising approach to the treatment of solid tumors and age-related macular degeneration (AMD). Inhibition of vascularization has been validated by the successful marketing of monoclonal antibodies (mAbs) that target speci
Autor:
Robert Mabry, John G. McManus
Publikováno v:
Critical Care Medicine. 36:S258-S266
Background Historic advances in combat prehospital care have been made in the last decade. Unlike other areas of critical care, most of these innovations are not the result of significant improvements in technology, but by conceptual changes in how c